Prosecution Insights
Last updated: April 19, 2026

Oryzon Genomics S A

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18554241 COMBINATIONS OF LSD1 INHIBITORS FOR TREATING MYELOID CANCERS SHIAO, REI TSANG 1691 Non-Final OA Oct 06, 2023
18455098 VAFIDEMSTAT FOR USE IN TREATING AUTISM SPECTRUM DISORDERS VISHNYAKOVA, ELENA VLADIMIROVNA 1691 Non-Final OA Aug 24, 2023
17441758 COMBINATIONS OF IADADEMSTAT FOR CANCER THERAPY YOUNGBLOOD, WILLIAM JUSTIN 1629 Final Rejection Sep 22, 2021
17439584 METHODS OF TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER USING KDM1A INHIBITORS SUCH AS THE COMPOUND VAFIDEMSTAT GONZALEZ, LUISALBERTO 1624 Final Rejection Sep 15, 2021

Managing Oryzon Genomics S A's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month